Inhibition of feline infectious peritonitis virus replication by recombinant human leukocyte (alpha) interferon and feline fibroblastic (beta) interferon.
Replication of feline infectious peritonitis virus (FIPV) in feline cell cultures was inhibited after incubation of cells with either human recombinant leukocyte (alpha) interferon (IFN) or feline fibroblastic (beta) IFN for 18 to 24 hours before viral challenge exposure. Compared with virus control cultures, FIPV yields were reduced by ranges of 0.1 to 2.7 log10 or 2 to 5.2 log10 TCID50 in cultures treated with human alpha- or feline beta-IFN, respectively; yield reductions were IFN dose dependent. Sensitivity to the antiviral activities of IFN varied with cell type; feline embryo cells had greater FIPV yield reductions than did similarly treated feline kidney or feline lung cells. Comparison of the virus growth curves in IFN-treated and virus control cultures indicated marked reduction in intracellular and extracellular FIPV in IFN-treated cultures. Compared with virus control cultures, intracellular and extracellular infectivity in IFN-treated cultures was delayed in onset by 12 and 30 hours, respectively, and FIPV titers subsequently were reduced by 3 to 3.5 and 5 log10 TCID50, respectively. Frequently, immunofluorescent and electron microscopy of IFN-treated cells or cell culture fluids did not reveal virus; however, even in cultures without viral cytopathic changes, small amounts of virus occasionally persisted in cells.
Weiss
R C
RC
Scott-Ritchey Research Program, College of Veterinary Medicine, Auburn University, AL 36849.
Toivio-Kinnucan
M
M
D000818:Animals; D002415:Cats; D002478:Cells, Cultured; D003332:Coronaviridae / Q000502:physiology* / Q000648:ultrastructure; D003588:Cytopathogenic Effect, Viral; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D008854:Microscopy, Electron; D011994:Recombinant Proteins; D014779:Virus Replication
D007370:Interferon Type I; D011994:Recombinant Proteins